Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             25 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A brave NEO world: Neoadjuvant osimertinib in resectable EGFR-mutant NSCLC Cortiula, F.

181 C p.
artikel
2 Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion Pan, Yingying

181 C p.
artikel
3 Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial Shimokawa, Tsuneo

181 C p.
artikel
4 Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI’s: Exploration of efficacy of unselected treatment in a multicenter cohort study Steendam, Christi M.J.

181 C p.
artikel
5 Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC Heenatigala Palliyage, Gayathri

181 C p.
artikel
6 China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopy Zhang, Yanwei

181 C p.
artikel
7 Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms Ferencz, Bence

181 C p.
artikel
8 Comparison of electromagnetic navigation bronchoscopy and transthoracic needle biopsy for diagnosing bronchus sign-positive pulmonary lesions Wook Kim, Yeon

181 C p.
artikel
9 Contents
181 C p.
artikel
10 Development and validation of a simple general population lung cancer risk model including AHRR-methylation Jacobsen, Katja Kemp

181 C p.
artikel
11 EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors Shaffer, William

181 C p.
artikel
12 Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study Tian, Jie

181 C p.
artikel
13 Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer Alsaddah, Saba

181 C p.
artikel
14 Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors Tsutsumi, Hirono

181 C p.
artikel
15 KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma Gallina, F.T.

181 C p.
artikel
16 Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples Ilié, Marius

181 C p.
artikel
17 Multimodality therapy for lung cancer invading the chest wall: A study of the French EPITHOR database Tricard, Jérémy

181 C p.
artikel
18 Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma Hong, Hui-Zhao

181 C p.
artikel
19 Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study Sänger, Jonathan A.

181 C p.
artikel
20 Pre-existing tumor host immunity characterization in resected non-small cell lung cancer Rocha, Pedro

181 C p.
artikel
21 Real-world outcomes in patients with KRAS G12C–mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond Gray, Jhanelle E.

181 C p.
artikel
22 Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands ten Berge, Deirdre M.H.J.

181 C p.
artikel
23 Retraction notice to “Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors” [Lung Cancer 71 (2011) 283–290] Morgillo, Floriana

181 C p.
artikel
24 Systemic treatment for neuroendocrine non-small cell lung carcinoma: A cases series and a systematic review of the literature Jelli, Blandine

181 C p.
artikel
25 The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies? Pezzuto, Federica

181 C p.
artikel
                             25 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland